Exploratory, Phase 0 Study of Positron Emission Tomography (PET) Imaging Agent, F-18 RGD-K5
Efficacy Study of [F-18]RGD-K5 Positron Emission Tomography (PET) as a Tool to Monitor Response to an Anti-angiogenic Drug
[F-18] RGD-K5 Positron Emission Tomography (PET) in Participants With Carotid Artery Stenosis
TRACER RGD-K5 Carotid Plaque Imaging Study
RGD-K5 in Head and Neck Cancer Patients
† Study has passed its completion date and status has not been verified in more than two years.